Lu Wang

Lu Wang

Auto-generated profile, based on publicly available information

Lu Wang

Department of Bioinformatics, Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in mSystems
Verified
Journal Article
Open access
LWLu Wang
Lu Wang
YXYi-Ning Xu
Yi-Ning Xu
CCChung-Ching Chu
Chung-Ching Chu
ZJZehua Jing
Zehua Jing
YCYabin Chen
Yabin Chen
LCLuonan Chen
Luonan Chen
The association between the skin microbiome and skin health has been widely reported. However, the role of the skin microbiome in mediating skin physiology remains a challenging and yet priority subject in the field.

23 July 2025 in The EMBO Journal
Verified
Journal Article
Open access
WSWenlong Shang
Wenlong Shang
YLYinxiu Li
Yinxiu Li
LWLu Wang
Lu Wang
JLJiao Liu
Jiao Liu
HRHuiwen Ren
Huiwen Ren
YYYing Yu
Ying Yu
Macrophages are primary immune cells involved in obesity-triggered chronic low-grade inflammation in adipose tissues. Prostaglandin E2 (PGE 2 ), mainly generated from macrophages, can regulate adipose tissue remodeling, yet the underlying mechanisms are not fully understood. Here, we observed that PGE 2 receptor subtype 3 (EP3) was remarkably downregulated in adipose tissue macrophages from high-fat diet (HFD)-fed mice and patients with obesity. Notably, macrophage-specific deletion of EP3 exacerbated HFD-induced fat expansion, whereas EP3α isoform overexpression in macrophages alleviated obesity phenotypes. Further, EP3 deficiency suppressed secretion of anti-adipogenic matricellular protein SPARC from macrophages. SPARC deletion in macrophages abrogated the protection of EP3-overexpression against diet-induced obesity. Mechanistically, EP3 activation promoted SPARC expression by suppressing DNA methylation in macrophages through a PKA-Sp1-Dnmt1/3a signaling cascade. Finally, EP3 agonist treatment ameliorated HFD-induced obesity in mice. Thus, EP3 inhibits adipogenesis through promoting release of SPARC from macrophages, suggesting a novel therapeutic target for diet-induced obesity.

5 November 2025 in Intelligent Medicine
Verified
Journal Article
Open access
LWLu Wang
Lu Wang
HLHan Lyu
Han Lyu
BSBin Sheng
Bin Sheng